Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
89.2M
-
Shares change
-
+13.5M
-
Total reported value, excl. options
-
$2.28B
-
Value change
-
+$379M
-
Put/Call ratio
-
0.51
-
Number of buys
-
84
-
Number of sells
-
-69
-
Price
-
$25.52
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q1 2024
180 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q1 2024.
Avidity Biosciences, Inc. - Common Stock (RNA) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.2M shares
of 120M outstanding shares and own 74.3% of the company stock.
Largest 10 shareholders include FMR LLC (14.2M shares), RTW INVESTMENTS, LP (7.97M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.43M shares), BlackRock Inc. (6.17M shares), Avoro Capital Advisors LLC (5.83M shares), COWEN AND COMPANY, LLC (5.63M shares), VANGUARD GROUP INC (3.85M shares), STATE STREET CORP (3.46M shares), RA CAPITAL MANAGEMENT, L.P. (3.28M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (2.4M shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.